IGC Pharma, LLC
NYSE IGC · Potomac, MD
Works in Neurology · Psychiatry
IGC Pharma, LLC is a clinical trial sponsor based in Potomac, MD, listed as NYSE IGC. It has 1 active clinical trial with 164 planned participants, in Neurology and Psychiatry. Since 2021 it has completed 1 trial and stopped 0 early.
Trial track record · since 2021
Financials · NYSE IGC
Fundraising
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about IGC Pharma, LLC
IGC Pharma, LLC is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 164 planned participants, in Neurology, Psychiatry. Since 2021 it has completed 1 trial and stopped 0 early.
IGC Pharma, LLC is based in Potomac, MD and is listed as NYSE IGC. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with IGC Pharma, LLC; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-30.
Approve Suite is not affiliated with IGC Pharma, LLC.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.